First National Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,489
| Closed | -$302K | – | 376 |
|
|
2023
Q2 | $302K | Sell |
3,489
-6,062
| -63% | -$525K | 0.01% | 318 |
|
|
2023
Q1 | $929K | Sell |
9,551
-2,387
| -20% | -$232K | 0.05% | 205 |
|
|
2022
Q4 | $1.24M | Sell |
11,938
-9,721
| -45% | -$1.01M | 0.07% | 173 |
|
|
2022
Q3 | $1.84M | Sell |
21,659
-59,869
| -73% | -$5.08M | 0.11% | 152 |
|
|
2022
Q2 | $6.76M | Sell |
81,528
-2,331
| -3% | -$193K | 0.38% | 75 |
|
|
2022
Q1 | $6.47M | Buy |
83,859
+6,874
| +9% | +$530K | 0.34% | 89 |
|
|
2021
Q4 | $6.8M | Buy |
76,985
+5,129
| +7% | +$453K | 0.36% | 89 |
|
|
2021
Q3 | $5.55M | Buy |
71,856
+3,099
| +5% | +$240K | 0.33% | 88 |
|
|
2021
Q2 | $5.74M | Buy |
68,757
+13,455
| +24% | +$1.12M | 0.35% | 90 |
|
|
2021
Q1 | $4.18M | Buy |
+55,302
| New | +$4.18M | 0.27% | 99 |
|